The CDC report found that both a lackluster oversight system and inadequate standard protocols to document when biological agents are properly inactivated unnecessarily puts CDC employees at risk. In addition to the agency’s moratorium on the movement of biohazardous materials at biosafety level 3 and level 4 facilities, the agency also plans to establish a high-level working group that will report directly to Frieden. It will oversee improvements in safety on a lab-by-lab basis.